Healthcare Realty Trust (NYSE:HR) Issues FY 2024 Earnings Guidance

Healthcare Realty Trust (NYSE:HR) updated its FY 2024 earnings guidance on Saturday. The company provided EPS guidance of 1.530-1.580 for the period, compared to the consensus EPS estimate of 1.550. The company issued revenue guidance of -.

Healthcare Realty Trust Trading Up 0.2 %

Shares of HR stock opened at $17.94 on Friday. The business’s 50-day moving average price is $17.81 and its 200-day moving average price is $16.06. The firm has a market capitalization of $6.79 billion, a price-to-earnings ratio of -13.49 and a beta of 0.91. Healthcare Realty Trust has a 12 month low of $12.77 and a 12 month high of $18.90.

Healthcare Realty Trust (NYSE:HR) last announced its earnings results on Friday, August 2nd. The real estate investment trust reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.38 by ($0.77). Healthcare Realty Trust had a negative return on equity of 8.50% and a negative net margin of 42.79%. The company had revenue of $316.30 million for the quarter, compared to the consensus estimate of $317.90 million. During the same period in the prior year, the business earned $0.39 earnings per share. The firm’s revenue for the quarter was down 6.4% on a year-over-year basis. On average, sell-side analysts predict that Healthcare Realty Trust will post 1.56 earnings per share for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Shareholders of record on Monday, August 12th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 6.91%. The ex-dividend date was Monday, August 12th. Healthcare Realty Trust’s dividend payout ratio is presently -93.23%.

Analysts Set New Price Targets

HR has been the subject of several recent analyst reports. Wells Fargo & Company cut shares of Healthcare Realty Trust from an equal weight rating to an underweight rating and decreased their price objective for the stock from $17.00 to $16.00 in a research report on Tuesday, July 30th. Wedbush lifted their target price on Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a neutral rating in a report on Monday, August 5th. Finally, Scotiabank boosted their price target on Healthcare Realty Trust from $17.00 to $18.00 and gave the company a sector perform rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $17.00.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director John Knox Singleton bought 6,500 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were bought at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the acquisition, the director now directly owns 57,082 shares of the company’s stock, valued at approximately $1,041,175.68. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director John Knox Singleton bought 6,500 shares of the stock in a transaction dated Thursday, September 5th. The stock was bought at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the acquisition, the director now directly owns 57,082 shares in the company, valued at approximately $1,041,175.68. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Thomas N. Bohjalian purchased 9,000 shares of the company’s stock in a transaction that occurred on Monday, August 12th. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $156,510.00. Following the completion of the transaction, the director now directly owns 22,252 shares of the company’s stock, valued at $386,962.28. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 15,728 shares of company stock worth $279,069. 0.56% of the stock is owned by corporate insiders.

About Healthcare Realty Trust

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.